XENE Q2 2021 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

XENEXenon Pharmaceuticals Inc.

$5B

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-83.4% YoY

Gross Profit

-$16M-728.5% margin

Operating Income

-$22M-1014.3% margin

Net Income

-$22M-996.8% margin

EPS (Diluted)

$-0.53

QoQ Revenue Growth

-49.1%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$14M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$275M

Total Liabilities

$18M

Stockholders' Equity

$257M

Cash & Equivalents

$83M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$13M	-83.4%
Gross Profit	-$16M	$13M	-220.7%
Operating Income	-$22M	-$646,000	-3382.7%
Net Income	-$22M	-$175,000	-12533.7%

Revenue Segments

License And Service

$2M100%